Literature DB >> 18423413

Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol.

Muhammad Zahid1, Nilesh W Gaikwad, Mohamed F Ali, Fang Lu, Muhammad Saeed, Li Yang, Eleanor G Rogan, Ercole L Cavalieri.   

Abstract

Resveratrol (Resv), a natural occurring phytolexin present in grapes and other foods, possesses chemopreventive effects revealed by its striking modulation of diverse cellular events associated with tumor initiation, promotion, and progression. Catechol estrogens generated in the metabolism of estrogens are oxidized to catechol quinones that react with DNA to form predominantly depurinating estrogen-DNA adducts. This event can generate the mutations responsible for cancer initiation. In this regard, Resv acts as both an antioxidant and an inducer of the phase II enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1). In this report, we present the effects of Resv on the metabolism of estrogens in normal breast epithelial cells (MCF-10F) treated with 4-hydroxyestradiol (4-OHE(2)) or estradiol-3,4-quinone (E(2)-3,4-Q). Resv induced NQO1 in a dose- and time-dependent manner, but did not affect the expression of catechol-O-methyltransferase. Ultraperformance liquid chromatography/tandem mass spectrometry was used to determine the effects of Resv on estrogen metabolism. Preincubation of the cells with Resv for 48 h decreased the formation of depurinating estrogen-DNA adducts from 4-OHE(2) or E(2)-3,4-Q and increased formation of methoxycatechol estrogens. When Resv was also present with the 4-OHE(2) or E(2)-3,4-Q, even greater increases in methoxycatechol estrogens were observed, and the DNA adducts were undetectable. We conclude that Resv can protect breast cells from carcinogenic estrogen metabolites, suggesting that it could be used in breast cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423413      PMCID: PMC2494714          DOI: 10.1016/j.freeradbiomed.2008.03.017

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  34 in total

1.  Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene.

Authors:  D Chakravarti; P C Mailander; K M Li; S Higginbotham; H L Zhang; M L Gross; J L Meza; E L Cavalieri; E G Rogan
Journal:  Oncogene       Date:  2001-11-29       Impact factor: 9.867

2.  Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity.

Authors:  Maura Floreani; Eleonora Napoli; Luigi Quintieri; Pietro Palatini
Journal:  Life Sci       Date:  2003-05-02       Impact factor: 5.037

Review 3.  Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies.

Authors:  F Peter Guengerich; Young-Jin Chun; Donghak Kim; Elizabeth M J Gillam; Tsutomu Shimada
Journal:  Mutat Res       Date:  2003 Feb-Mar       Impact factor: 2.433

4.  Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.

Authors:  S Dawling; N Roodi; R L Mernaugh; X Wang; F F Parl
Journal:  Cancer Res       Date:  2001-09-15       Impact factor: 12.701

5.  Semiquinone radical intermediate in catecholic estrogen-mediated cytotoxicity and mutagenesis: chemoprevention strategies with antioxidants.

Authors:  Ayelet M Samuni; Eric Y Chuang; Murali C Krishna; William Stein; William DeGraff; Angelo Russo; James B Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

6.  Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.

Authors:  L Tessitore; A Davit; I Sarotto; G Caderni
Journal:  Carcinogenesis       Date:  2000-08       Impact factor: 4.944

7.  Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.

Authors:  Y Markushin; W Zhong; E L Cavalieri; E G Rogan; G J Small; E S Yeung; R Jankowiak
Journal:  Chem Res Toxicol       Date:  2003-09       Impact factor: 3.739

Review 8.  Cancer chemopreventive activity of resveratrol.

Authors:  Krishna P L Bhat; John M Pezzuto
Journal:  Ann N Y Acad Sci       Date:  2002-05       Impact factor: 5.691

9.  Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells.

Authors:  Fang Lu; Muhammad Zahid; Cheng Wang; Muhammad Saeed; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Cancer Prev Res (Phila)       Date:  2008-07

Review 10.  Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).

Authors:  Moammir H Aziz; Raj Kumar; Nihal Ahmad
Journal:  Int J Oncol       Date:  2003-07       Impact factor: 5.650

View more
  32 in total

1.  Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

Authors:  Barbara Calamini; Kiira Ratia; Michael G Malkowski; Muriel Cuendet; John M Pezzuto; Bernard D Santarsiero; Andrew D Mesecar
Journal:  Biochem J       Date:  2010-07-15       Impact factor: 3.857

2.  Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Nimee K Bhat; Hari K Bhat
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

3.  Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease.

Authors:  Muhammad Zahid; Muhammad Saeed; Li Yang; Cheryl Beseler; Eleanor Rogan; Ercole L Cavalieri
Journal:  IUBMB Life       Date:  2011-11-02       Impact factor: 3.885

4.  Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland.

Authors:  Taehyun Kim; Hoyong Park; Wei Yue; Ji-Ping Wang; Kristen A Atkins; Zhenguo Zhang; Eleanor G Rogan; Ercole L Cavalieri; Khalid S Mohammad; Sanghee Kim; Richard J Santen; Sarah E Aiyar
Journal:  Breast Cancer Res Treat       Date:  2010-12-18       Impact factor: 4.872

Review 5.  The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

Authors:  Ercole Cavalieri; Eleanor Rogan
Journal:  Mol Aspects Med       Date:  2013-08-30

6.  N-acetylcysteine blocks formation of cancer-initiating estrogen-DNA adducts in cells.

Authors:  Muhammad Zahid; Muhammad Saeed; Mohammed F Ali; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2010-05-31       Impact factor: 7.376

7.  The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.

Authors:  Marian Y Williams-Brown; Sana M Salih; Xia Xu; Timothy D Veenstra; Muhammad Saeed; Shaleen K Theiler; Concepcion R Diaz-Arrastia; Salama A Salama
Journal:  J Steroid Biochem Mol Biol       Date:  2011-05-10       Impact factor: 4.292

Review 8.  Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers.

Authors:  Ercole L Cavalieri; Eleanor G Rogan
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

Review 9.  Modulation of estrogen synthesis and metabolism by phytoestrogens in vitro and the implications for women's health.

Authors:  Majorie B M van Duursen
Journal:  Toxicol Res (Camb)       Date:  2017-09-08       Impact factor: 3.524

Review 10.  NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector.

Authors:  Albena T Dinkova-Kostova; Paul Talalay
Journal:  Arch Biochem Biophys       Date:  2010-03-31       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.